Stoke Therapeutics, Inc. ($STOK)
Leggett Thomas โ Chief Financial Officer
Shares
14,750
Price
$0.00
Total Value
$0.00
Nearby Earnings
Mar 17, 2026
EPS:-0.99 (est: -0.92)+8.1%
Revenue:$1.40M (est: $6.24M)-77.5%
Transaction Details
| Insider | Leggett Thomas |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Mar 15, 2026 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 17, 2026 |
| Shares Purchased | 14,750 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 14,750 |
| Derivative | No |
| Accession Number | 0001774690-26-000004 |
| Document | View SEC Filing |